02185.HK
Shanghai Bio-heart Biological Technology Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 1.47
−8.13%Sep 14, 2026, 23:16 UTC
Shanghai Bio-Heart Biological Technology entered into a strategic cooperation agreement with Shenqi Medical to jointly advance the commercialization and clinical application of the Bioheart® bioresorbable rapamycin-eluting coronary stent system.
Source:Sep 14, 2026, 23:10 UTC
Bioheart Inc. (02185) announced that it recently entered into a strategic cooperation agreement with Shanghai Shenqi Medical to jointly advance the commercialization and clinical application of its independently developed Bioheart bioresorbable rapamycin-eluting coronary stent system (BioHeart stent).
Source: